AwardTape · Defense awards · Research and development · Health R&D · W81XWH22C0092
W81XWH22C0092: $118K definitive contract to George Washington University (the)
George Washington University (the) holds a definitive contract from Defense Health Agency with $118K obligated since Oct 2023 and $342K obligated over its life, against a ceiling of $342K. Latest action Jul 21, 2024.
Mep pathway inhibitor synthesis services
| PIID | W81XWH22C0092 |
|---|---|
| Type | definitive contract |
| Company | George Washington University (the) |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN11 HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $118K |
| Total obligated (lifetime) | $342K |
| Ceiling (base and all options) | $342K |
| Base date | Jul 27, 2022 |
| Latest action | Jul 21, 2024 |
| End date | Aug 25, 2025 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Place of performance | DC |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial